KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg)

Mechanism of Action: How the KLOW Blend Works

Each peptide contributes a unique biological pathway:

• GHK-Cu — Collagen + elastin synthesis, antioxidant skin repair
• KPV — α-MSH fragment that suppresses inflammatory cytokines
• BPC-157 — Angiogenesis + gut-brain healing axis activation
• TB500 — Actin upregulation + tissue-regeneration acceleration

When combined, KLOW creates:

• Rapid structural repair across soft tissue and connective systems
• Major inflammation reduction supporting chronic-injury recovery
• Cellular protection against oxidative and immune stress

This blend is built for enhanced healing outcomes beyond single-target therapy.

Clinical Dosing Guide for Providers

For licensed medical professionals only.

Suggested Dosage

• Common Range: 200–400mcg daily
• Cycle Duration: 4–12+ weeks based on severity and tissue type

Administration Notes

• Route: Subcutaneous injection (near injury recommended if appropriate)

Common Clinical Stacks

• GH Secretagogues (CJC-1295 / Ipamorelin) — synergistic recovery signaling
• AOD-9604 — fat-loss + inflammation support
• TA1 — immune-repair combination

Reconstitution & Storage

• Reconstitute with bacteriostatic water
• Refrigerate immediately after mixing
• ~30-day stability refrigerated

Ideal Candidate Profile

Potentially Good Candidates

• Athletes recovering from injuries or high-training volume
• Patients with chronic inflammation–linked pain
• Individuals with tendonitis, muscle tears, joint strain
• Post-surgical healing support cases
• Those with skin-healing or GI-barrier impairments

Use With Caution

• Severe autoimmune cases — increased monitoring advised
• Active cancer — requires specialist involvement

Potential Side Effects

Well tolerated due to its non-hormonal profile:

• Minor injection-site redness
• Temporary inflammatory reaction during tissue remodeling
• Rare fatigue during high-dose recovery cycles

Adverse reactions are uncommon with professional oversight.

Frequently Asked Questions

1. What is the primary goal of the KLOW blend?
Maximizing tissue repair while reducing inflammation.

2. Does it help with chronic injuries?
Yes — especially tendon, ligament, and joint areas.

3. Does it affect muscle growth?
Indirectly — faster recovery enables better training outcomes.

4. Is it good for skin healing?
Yes — GHK-Cu strongly supports dermal regeneration.

5. Can it help the gut?
Yes — BPC-157 + KPV support GI barrier repair.

6. Does it work fast?
Injury-pain reduction can begin within days to weeks.

7. Is it safe long-term?
Typically used in cycles aligned with healing timelines.

8. Can it replace surgery?
No — but may improve outcomes before or after procedures.

9. Will inflammation go away permanently?
Depends on the condition — reduces symptoms and promotes healing.

10. How should it be stored?
Refrigerated after reconstitution.

KLOW Blend vs Single-Peptide Therapies

• vs BPC-157 Alone:
  KLOW adds faster connective-tissue + skin repair pathways.
• vs TB-500 Alone:
  Additional anti-inflammatory + gut healing benefits.
• vs GHK-Cu Alone:
  Full-system recovery rather than cosmetic-focused effects.

Research & Evidence Overview

The combined pathways support:

• Faster muscle, tendon, and skin recovery
• Governed inflammatory reduction
• Improved vascularization + tissue remodeling
• Improved quality-of-life outcomes in injury rehab

A multi-mechanism therapeutic advancing regenerative clinical care.

Product & Purity Assurance

99% purity pharmaceutical grade

• COA + endotoxin tested
• cGMP manufacturing and handling
• Medical-provider exclusive distribution

Legal & Medical Disclaimer

For licensed medical professionals only. Not intended to diagnose, treat, or cure any condition.